We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2008 by Stanford University.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00801762
First Posted: December 3, 2008
Last Update Posted: December 3, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Mauna Kea Technologies
Information provided by:
Stanford University
  Purpose
The goal of the study is to develop a novel approach to obtain real time optical biopsy of urinary tract pathology (e.g., bladder tumors) during urinary tract endoscopy using a novel fibered confocal microscope.

Condition Intervention
Bladder Cancer Device: Fibered confocal microscope

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology

Resource links provided by NLM:


Further study details as provided by Stanford University:

Estimated Enrollment: 30
Study Start Date: September 2008
Estimated Study Completion Date: June 2009
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
Inclusion Criteria:Research subjects with suspected urinary tract pathology (e.g., bladder tumors) who are scheduled to undergo cystoscopy with possible excisional biopsy (e.g. transurethral resection of bladder tumor) in the operating room.
 Exclusion Criteria:History of hypersensitivity to fluorescein; active urinary tract infection; pregnant; currently breast feeding;
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00801762


Contacts
Contact: Jospeh C Liao, M.D. (650) 852-3284 jliao@stanford.edu

Locations
United States, California
VA Palo Alto Health Care System Recruiting
Palo Alto, California, United States, 94304
Contact: Jospeh C Liao, M.D.    650-852-3284    jliao@stanford.edu   
Sponsors and Collaborators
Stanford University
Mauna Kea Technologies
Investigators
Principal Investigator: Joseph C. Liao Stanford University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00801762     History of Changes
Other Study ID Numbers: SU-10142008-1319
First Submitted: December 2, 2008
First Posted: December 3, 2008
Last Update Posted: December 3, 2008
Last Verified: December 2008

Additional relevant MeSH terms:
Urinary Bladder Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Urinary Bladder Diseases
Urologic Diseases